About aescuvest
-
read full story
29.09.2021
The rise of the unicorns: 1000% growth in a 5-year span!
One could say, the global unicorn club has been growing to a bigger degree during the past 5 years than since the first unicorns ever were born in the 90’s.
-
read full story
23.09.2021
CRISPR: Destruction or Disruption?
How CRISPR could be changing the world
-
read full story
15.09.2021
European Investments nearly doubled!
While it would be wrong to talk about "the Europeans", since it is inadequate to paint the picture of European folks with a broad brush, it is still possible to identify some cultural and hence ideological differences between north Americans and Europeans. What first comes into mind is a PEW research center survey from 2012 that showcased the "American-Western European Value Gap" and identified some very interesting facts.
-
read full story
15.08.2021
Making an impact: Investing with a purpose
There are all types of investors out there – and you most likely found yourself in the position of thinking about what your investment is enabling in the real economy next to thinking about your margin. The awareness for the health of our planet and our society rose strongly within the past decades. While people during the industrialization, and all the years after, cared little to not at all about the “impact” of their money on the planet, this became an important parameter for investment decisions in our world today.
-
read full story
29.12.2020
The future of digital diabetes management: The ESYSTA Pen 2.0
On achieving the 3-million-euro financing threshold, Emperra plans to start the development of the ESYSTA Pen 2.0. But why? How will it differ from the current ESYSTA Pen? And why is this such an important factor for Emperra's international growth? Find out the answers to these questions and more in the following article.
-
read full story
17.12.2020
What do the studies say? The benefit of the ESYSTA System is clinically proven.
It is possibly the most pertinent question regarding the ESYSTA System: Is it beneficial? Or in more technical terms: Does using ESYSTA have a medical benefit for diabetes patients and if so, what is that benefit? These questions are not only at the forefront for patients, doctors and health insurance providers, Emperra, as the developer of the ESYSTA System, also wanted a straight answer.
-
read full story
10.12.2020
The advantages of Emperra’s ESYSTA System
A diabetes diary is the most important source of data for successful diabetes treatment. Diabetes patients are required to enter their values in these diaries daily, sometimes up to 6 times a day. Gaps, mistakes or errors can complicate treatment. Alarmingly, however, meticulously kept diabetes diaries are a rarity.
-
read full story
03.12.2020
The benefits of digitalisation for the healthcare sector
Digitalisation is not an end in itself but instead is gaining more and more traction in all areas of life due to the sum of its benefits. This naturally also applies to the benefits for the healthcare sector: In this sector, digital technologies and products such as, e.g. Emperra's ESYSTA system have the potential to overcome the major challenges of the upcoming years and decades, including demographic change, the consistent increase of chronic diseases and insufficient access to healthcare in economically underdeveloped, rural areas.
-
read full story
27.11.2020
Why the German Digital Healthcare Act (DVG) is triggering such major investments
Digitalisation has the potential to genuinely improve the provision of healthcare in Germany. However, until recently, the integration of digital solutions was possible to only a very limited extent due to the general parameters of the German healthcare system. The German Digital Healthcare Act (Digitale-Versorgung-Gesetz, DVG) has now created conditions that do justice to the dynamism of digital transformation and the speed of its processes.
-
read full story
19.11.2020
How the DVG is improving the scalability of Emperra’s digital services
The German Digital Healthcare Act is a major milestone on the path to the digitalisation of the German healthcare system. This development is fully in line with Emperras strategic focus.
-
read full story
12.11.2020
Why experts are warning of a diabetes epidemic
Diabetes mellitus, and in particular type 2 diabetes, is becoming an affliction of global proportion. In 2006, the International Diabetes Federation (IDF) already referred to the issue as "THE epidemic of the 21st century". Unfortunately, this prediction has turned out to be virtually on point.
-
read full story
10.07.2020
Investors in the Time of the Pandemic Meet Virtually at the Sachsforum
This week, the digital Novel Coronavirus Investment Forum (NCIF) offered a forward-looking analysis of the revolution in healthcare
Get notified
of new campaigns and news.
We do not sell or share your data to third parties. View our Privacy notice